Enrique Martínez-Pías
5PUBLICATIONS
7CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (5)
Sort by Publication Date:
|Jul 02, 2021
Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.Enrique Martínez-Pías, Ángel L Guerrero, Álvaro Sierra
|Oct 28, 2020
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients.Enrique Martínez-Pías, David García-Azorín, Ane Minguez-Olaondo
|Aug 14, 2020
Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.David García-Azorín, Javier Trigo, Blanca Talavera
|Jul 06, 2019
Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study.David García-Azorín, Javier Trigo-López, Álvaro Sierra
|Mar 22, 2019
Epicrania Fugax as the presenting symptom of a cerebellar abscess.David García-Azorín, Julio Dotor García-Soto, Enrique Martínez-Pías
Pageof 1
